Matthew Hamilton Rosenberg’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Matthew Hamilton Rosenberg’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-6,108	Closed	-$207K	–	830
2026 Q2	$207K	Hold	6,108	–	–	0.04%	221
2026 Q1	$184K	Hold	6,108	–	–	0.04%	228
2025 Q4	$191K	Hold	6,108	–	–	0.04%	214
2025 Q3	$123K	Hold	6,108	–	–	0.03%	289
2025 Q2	$102K	Hold	6,108	–	–	0.02%	324
2025 Q1	$93.9K	Hold	6,108	–	–	0.02%	326
2024 Q4	$135K	Hold	6,108	–	–	0.04%	256
2024 Q3	$110K	Hold	6,108	–	–	0.03%	306
2024 Q2	$99.8K	Hold	6,108	–	–	0.03%	296
2024 Q1	$85K	Hold	6,108	–	–	0.02%	339
2023 Q4	$63.8K	Hold	6,108	–	–	0.02%	389
2023 Q3	$62.3K	Hold	6,108	–	–	0.02%	384
2023 Q2	$46K	Buy	6,108 +1	+0%	+$8	0.02%	448
2023 Q1	$54K	Hold	6,107	–	–	0.02%	447
2022 Q4	$55.7K	Hold	6,107	–	–	0.02%	431
2022 Q3	$49K	Hold	6,107	–	–	0.02%	442
2022 Q2	$48K	Buy	6,107 +1,107	+22%	+$9.64K	0.02%	470
2022 Q1	$47K	Hold	5,000	–	–	0.02%	470
2021 Q4	$40K	Hold	5,000	–	–	0.01%	452
2021 Q3	$49K	Hold	5,000	–	–	0.02%	397
2021 Q2	$50K	Hold	5,000	–	–	0.03%	357
2021 Q1	$58K	Hold	5,000	–	–	0.03%	330
2020 Q4	$48K	Hold	5,000	–	–	0.03%	334
2020 Q3	$45K	Hold	5,000	–	–	0.03%	320
2020 Q2	$62K	Hold	5,000	–	–	0.05%	276
2020 Q1	$45K	Buy	+5,000	New	+$51.2K	0.04%	274

Other funds holding TEVA

WWM

Whalen Wealth Management Las Vegas, Nevada $234M AUM 28.06% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

CAM

Cacti Asset Management Atlanta, Georgia $1.89B AUM 58.55% 1-Year Est. Return

IRC

Investors Research Corp Atlanta, Georgia $569M AUM 15.41% 1-Year Est. Return

VEM

Vann Equity Management Plano, Texas $168M AUM

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

GWM

Gilpin Wealth Management Denver, Colorado $148M AUM 25.13% 1-Year Est. Return

BAM

Byrne Asset Management Kingston, New Jersey $179M AUM 29.67% 1-Year Est. Return

EWP

Elevation Wealth Partners Santa Rosa, California $356M AUM 17.04% 1-Year Est. Return

AAG

Armstrong Advisory Group Needham, Massachusetts $1.66B AUM 13.15% 1-Year Est. Return

Matthew Hamilton Rosenberg's TEVA Position: Q3 2026 in Review

Matthew Hamilton Rosenberg sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q3 2026, closing a stake of 6,108 shares — an estimated $207K sold.

Matthew Hamilton Rosenberg first reported a position in TEVA in Q1 2020 and held it in 26 quarters. The position peaked at $207K in Q2 2026. 10 funds tracked by Wall St. Rank hold TEVA as of Q3 2026.

Matthew Hamilton Rosenberg reported no remaining Teva Pharmaceutical Industries Limited position as of Q3 2026 after selling out during the quarter.
Matthew Hamilton Rosenberg sold 6,108 Teva Pharmaceutical Industries Limited shares in Q3 2026, an estimated $207K.
Matthew Hamilton Rosenberg first reported a position in Teva Pharmaceutical Industries Limited in Q1 2020 and held it in 26 quarters.
Matthew Hamilton Rosenberg's Teva Pharmaceutical Industries Limited position peaked at $207K in Q2 2026.
10 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2026.

Based on Matthew Hamilton Rosenberg's 13F filing for Q3 2026, filed 5 Oct 2026.